Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights ...
Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...
Measurement – the Gold Standard for Heart Failure Diagnosis – Previously Only Obtainable Via Invasive Procedures PASADENA, Calif.--(BUSINESS WIRE)--#cardiology--Ventric Health, a medtech innovator ...
New technological developments in the cardiology field have increased collaboration to improve patient care, according to one cardiac surgeon. Frank Fazzalari, MD, who is the chief of cardiothoracic ...
The complex fluid–structure interaction underlying blood flow through vessels has proved challenging to analyze both ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, announced it has received CE Mark for the vMap® System, a non-invasive tool developed with AI that transforms ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...
Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...